Dopavision Reports Successful Completion of Enrollment for

- MyopiaX-1 trial to generate first clinical evidence with MyopiaX®, a novel therapeutic approach to manage myopia progression- First data readout expected...

Related Keywords

Moorfields ,Ballymena ,United Kingdom ,Portugal ,Netherlands ,Germany ,Berlin ,Dublin ,Ireland ,London ,City Of ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Madrid ,German ,Ludger Wess Ines Regina Buth ,Makula Netzhaut Zentrum Breyer Kaymak ,Novartis Pharma ,Mark Wuttke ,Dopavision Gmb ,University Complutense ,University Eye Hospital ,Boehringer Ingelheim Venture Fund ,German Federal Ministry Of Education ,Johannes Gutenberg University ,Ababax Health ,University Of Minho ,University Medical Center ,Technological University Dublin ,Centre For Eye Research Dublin ,Erasmus University Medical Center ,Data Safety Monitoring Board ,Netzhaut Zentrum Breyer Kaymak ,Eye Clinic ,Medical Center ,Sant Joan ,Eye Research Dublin ,Seventure Partners ,German Federal Ministry ,Ludger Wess ,Akampion ,Ophthalmology ,Childhood Myopia ,Myopia ,Myopia Control ,Digital Therapeutic ,Digital Health ,Opamine Stimulation ,Yopiax 174 ,